Age-associated cardiovascular changes are the substrate for poor prognosis with myocardial infarction**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.  by Lakatta, Edward G. & Schulman, Steven
EA
C
f
W
E
S
B
A
s
(
i
(

a
p
t
t
v
w
i
c
e
b
d
a
C
W
T
p
o
b
a
s
c
c
l
i
c
o
v
A
N
U
Journal of the American College of Cardiology Vol. 44, No. 1, 2004
© 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00
Published by Elsevier Inc. doi:10.1016/j.jacc.2004.04.011o
d
a
a
H
s
o
s
b
l
e
i
s
h
s
p
d
i
d
i
H
S
c
i
c
fl
e
T
n
t
L
o
s
f
a
e
a
N
C
T
h
i
c
a
c
t
d
c
p
cDITORIAL COMMENT
ge-Associated Cardiovascular
hanges Are the Substrate
or Poor Prognosis
ith Myocardial Infarction*
dward G. Lakatta, MD,†‡
teven Schulman, MD‡
altimore, Maryland
dvanced age is a powerful independent predictor of
hort-term mortality and morbidity in post-infarct patients
1–3). Randomized studies, including thousands of patients,
ndicate 10-fold increases in death, clinical heart failure
HF), and cardiogenic shock as age increases from 60 to
85 years (1). Although age differences in complications
nd mortality may relate in part to delayed and atypical
resentations and the increased likelihood of contraindica-
ions and complications from thrombolytic and beta-blocker
herapies (2), the pre-existing age-associated changes in
ascular and ventricular properties alter the substrate upon
hich the infarction occurs and probably play a crucial role
n the poor prognosis of elderly patients with acute myo-
ardial infarction (MI). In this issue of the Journal, Kurotobi
t al. (4) illustrate another example of the interaction
See page 28
etween age-related cardiovascular changes (endothelial
ysfunction) and disease (MI) and how this relationship has
negative impact on older patients with acute MI.
ARDIOVASCULAR CHANGES
ITH PHYSIOLOGIC AGING
here are several cardiovascular changes associated with
hysiologic aging that contribute to the poor prognosis in
lder patients with acute MI. These include decreased
eta-adrenergic sympathetic responsiveness (5,6), slowed
nd delayed early diastolic filling (7,8), increased vascular
tiffness (9,10), and endothelial dysfunction (11,12). De-
reased inotropic beta-adrenergic responsiveness may affect
ardiovascular function in the post-infarction period by
imiting contractile reserve in the region remote from the
nfarct and thereby the ability of that myocardium to
ompensate for the contractile performance lost as the result
f the infarct itself. Age-associated decreased early filling,
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †Laboratory of Cardiovascular Science, National Institute on Aging,
ational Institutes of Health, and the ‡Division of Cardiology, Johns Hopkinseniversity Medical Institutions, Baltimore, Maryland.n the order of 6% to 7% per decade (8), increases the
ependence of end-diastolic left ventricular (LV) volume on
trial contraction and is thought to result in higher left atrial
nd pulmonary pressures for any given stroke volume (13).
igher diastolic LV pressures may impair coronary perfu-
ion and contribute to adverse outcomes after infarction in
lder patients.
The age-associated increased arterial stiffness result from
everal factors, including fragmentation of the elastic mem-
rane, intimal thickening, increases in collagen content and
inking, decreased baroreflex sensitivity, and diminished
ndothelium-dependent vasorelaxation (5). These changes
ncrease the vascular load faced by the LV and exert a
ignificant influence on cardiovascular performance in
ealthy subjects (14–16). A relationship between arterial
tiffness, as indexed by sphygmomanometry-determined
ulse pressure and increased risk of future coronary heart
isease, congestive HF, and death, has been demonstrated
n elderly populations previously free of symptomatic heart
isease (17–19). In addition, elevated pulse pressure is an
ndependent predictor of mortality in patients with chronic
F and LV dysfunction after MI (20,21).
Aging is also associated with endothelial dysfunction.
tudies in subjects free of coronary artery disease and the
lassic risk factors for atherosclerosis demonstrate a signif-
cant inverse linear relationship between age and percent
hange in coronary and brachial arterial diameters and blood
ow responses to the intra-arterial administration of the
ndothelial-dependent vasodilator acetylcholine (11,12).
here is no age relationship for intra-arterial papaverine and
itroprusside, endothelial-independent vasodilators. Fur-
hermore, the inhibition of nitric oxide (NO) synthase with
-NMMA reduces forearm blood flow significantly less in
lder subjects than in younger subjects (22). These studies
uggest that in healthy subjects, the basal release of NO
rom vascular endothelium is reduced in the elderly, and the
ge-associated reduction in the vascular responsiveness to
ndothelium-dependent vasodilation in both the coronary
nd forearm circulation suggests a general diminution in
O vasodilation in all vascular beds (23).
URRENT STUDY
his important study by Kurotobi et al. (4) demonstrates
ow age-associated endothelial dysfunction has a negative
mpact on older patients with acute MI. Angiographic
ollateral blood flow was assessed in 1,934 patients with
cute MI and an occluded infarct vessel. The presence of
ollaterals decreased progressively with the increasing age of
he patient, and on multivariate analysis, age was indepen-
ently associated with a lesser prevalence of angiographic
ollaterals. As previous studies also have demonstrated,
reinfarction angina, a history of angina, and time to
atheterization were also related to the presence of collat-
rals. Unexplained, patients with circumflex infarcts were
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Editorial Comment July 7, 2004:35–7ess likely to have collateral blood flow. In older patients, the
ack of angiographic collaterals to the infarct vessel was an
ndependent predictor of mortality. Unanswered in this
tudy is whether older patients have a decreased ability to
evelop collaterals, or similar to many animal models, the
evelopment of collaterals is just delayed. Furthermore, a
ecreased ability to form collaterals in chronic coronary
isease may, a priori, put the elderly at increased risk to
evelop an MI.
Although the primary stimulus for collateral growth is
ontroversial, angiogenesis requires the proliferation and
igration of endothelial cells (24,25). With increasing age,
ndothelial dysfunction in collateral arterioles caused by a
eduction in endothelial NO synthase expression contrib-
tes to a decline in angiogenesis (25–27). Nitric oxide
ioavailability also is reduced in aged collateral arterioles
ecause of significantly greater amounts of superoxide and
itrated tyrosine residues of proteins (27). In addition to
ndothelial dysfunction, there is an age-related decrease in
ndothelial progenitor cells from the bone marrow (28) that
ikely limits the ability to form new blood vessels in response
o ischemia.
Another important link between age-associated endothe-
ial dysfunction and impaired collateral vessel growth is the
ecreased endothelial release of growth factors crucial for
ngiogenesis (26,29,30), including platelet-derived growth
actor-B (PDGF-B). The release of this growth factor
timulates the endothelial expression of several other growth
actors, including vascular endothelial-derived growth factor
VEGF) (29). Animal models show that the endothelial
xpression of PDGF-B is down-regulated in the senescent
eart, also resulting in the reduced expression of VEGF
29). In animal models of ischemia, VEGF messenger
ibonucleic acid and protein are reduced in aged animals,
esulting in significantly less perfusion pressure, angio-
raphic collateral vessel development, and capillary density
han in young animals (26). Pre-treating aged ischemic
nimals with VEGF protein, PDGF-AB, or bone marrow-
erived endothelial precursor cells from young animals
esults an increase in angiographically visible collaterals,
mproved perfusion pressure, improved angiogenesis, and a
eduction in myocardial infarct size (26,29,30). These stud-
es suggest that age-associated endothelial dysfunction re-
ults in reduced elaboration of endothelial-derived growth
actors in response to ischemia and impaired angiogenesis.
LINICAL IMPLICATIONS
he excess morbidity and mortality in older patients with
cute MI is an increasing challenge as the population ages.
he data from Kurotobi et al. (4) suggest that the estab-
ishment of normal coronary and myocardial blood flow in
n expeditious fashion is particularly important in older
atients with acute MI because the infarct vessel is less likely
o receive collateral flow than it is in younger patients. This
nding may help explain the impressive survival advantageor acute percutaneous coronary intervention compared with
hrombolytic therapy in the elderly (31). Whether therapies
hat enhance angiogenesis are particularly beneficial in the
lder patients with coronary disease awaits further study.
eprint requests and correspondence: Dr. Edward G. Lakatta,
aboratory of Cardiovascular Science, National Institute on Ag-
ng, National Institutes of Health, 5600 Nathan Shock Drive,
altimore, Maryland 21224. E-mail: lakattae@grc.nia.nih.gov.
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